Form 4 for NTLA Intellia Therapeutics, Inc.
Accepted 2025-07-03 00:00:00 ET · period of report 2025-07-02 · accession 0000950170-25-093844 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-03 | 2025-07-02 | NTLA | Dube Michael P | VP, CAO | S - Sale | $9.95 | -2,503 | 57.1K | -4% | -$24.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-02 | S | D | 2,503 | $9.95 | 57,137 | D | — | — |